HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,867 | -12.8% | 32,000 | -17.2% | 0.07% | +1.5% |
| Q2 2023 | $3,289 | -3.7% | 38,625 | -6.4% | 0.07% | -16.2% |
| Q1 2023 | $3,416 | +55.1% | 41,278 | +47.4% | 0.08% | +29.0% |
| Q4 2022 | $2,202 | -99.9% | 28,000 | +10.5% | 0.06% | +24.0% |
| Q3 2022 | $1,877,000 | +74.6% | 25,350 | +53.6% | 0.05% | +56.2% |
| Q2 2022 | $1,075,000 | +13.3% | 16,500 | +10.0% | 0.03% | +45.5% |
| Q1 2022 | $949,000 | -0.1% | 15,004 | -16.2% | 0.02% | +4.8% |
| Q4 2021 | $950,000 | -22.0% | 17,908 | +3.8% | 0.02% | -19.2% |
| Q3 2021 | $1,218,000 | +21.8% | 17,255 | +15.0% | 0.03% | +18.2% |
| Q2 2021 | $1,000,000 | +68.4% | 15,000 | +200.0% | 0.02% | +100.0% |
| Q4 2020 | $594,000 | -33.0% | 5,000 | -50.8% | 0.01% | -54.2% |
| Q3 2020 | $887,000 | -1.4% | 10,164 | +1.1% | 0.02% | -7.7% |
| Q2 2020 | $900,000 | +311.0% | 10,050 | +92.9% | 0.03% | +420.0% |
| Q4 2013 | $219,000 | -59.6% | 5,210 | -61.7% | 0.01% | -16.7% |
| Q3 2013 | $542,000 | – | 13,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |